## Core Concept
Beta-blockers are a class of medications that have a crucial role in the management of congestive heart failure (CHF). They work by blocking the effects of the hormone epinephrine, also known as adrenaline, and by slowing the heart rate and reducing its workload. This concept is fundamental in understanding their application in CHF.

## Why the Correct Answer is Right
The correct use of beta-blockers in CHF involves their initiation at a low dose with gradual titration to target doses or to a tolerated dose. This approach has been shown to improve survival, reduce hospitalizations, and improve symptoms in patients with stable heart failure. Beta-blockers are recommended for patients with heart failure with reduced ejection fraction (HFrEF) as part of guideline-directed therapy.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, incorrect statements might include claims that beta-blockers worsen heart failure symptoms immediately, which is not true when properly titrated.
- **Option B:** Similarly, without the content, we assume an incorrect statement might suggest beta-blockers have no role in CHF management, which contradicts evidence.
- **Option C:** An incorrect statement could propose that beta-blockers are contraindicated in all CHF patients, which is not accurate as they are beneficial for patients with HFrEF.
- **Option D:** Assuming this is the correct answer, the explanation would relate to the specifics of beta-blocker use in CHF, potentially highlighting an overstatement or incorrect generalization about their use.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that beta-blockers should be started at a low dose in patients with stable heart failure and gradually increased to the target dose or a tolerated dose. This approach minimizes the risk of worsening heart failure, which can occur with initial use.

## Correct Answer: D.